Internet Pioneer In...
Health Care: Drugs
Alkermes PLC (ALKS: NASDAQ)
$15.12 -0.50 | -3.20%
06/01/12 - 04:00 PM ET
Company Balance Sheet
| Mar 2012 | Mar 2011 | Mar 2010 | Mar 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 83.60M | 38.39M | 79.32M | 86.89M |
| Receivables | 96.38M | 22.97M | 25.32M | 24.59M |
| Inventories | 39.76M | 20.42M | 20.65M | 20.30M |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 339.15M | 252.96M | 338.28M | 376.05M |
| Property, Plant & Equipment, Gross | 416.30M | 186.73M | 185.92M | 179.70M |
| Accumulated Depreciation & Depletion | 113.31M | 91.71M | 89.01M | 73.23M |
| Property, Plant & Equipment, Net | 303.00M | 95.02M | 96.90M | 106.46M |
| Intangibles | 617.84M | 0.00 | 0.00 | 0.00 |
| Other Non-Current Assets | 82.48M | 104.47M | 80.41M | 83.98M |
| Total Non-Current Assets | 1.10B | 199.49M | 177.32M | 190.44M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 1.44B | 452.45M | 515.60M | 566.49M |
| Accounts Payable | 18.40M | 9.27M | 8.20M | 9.22M |
| Short Term Debt | 3.10M | 0.00 | 0.00 | 25.67M |
| Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Liabilities | 89.16M | 48.06M | 91.14M | 68.99M |
| Long Term Debt | 441.36M | 0.00 | 0.00 | 50.22M |
| Deferred Income Taxes | 34.51M | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 16.33M | 12.37M | 11.84M | 12.39M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 492.20M | 12.37M | 11.84M | 62.61M |
| Total Liabilities | 581.36M | 60.43M | 102.98M | 131.60M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 853.85M | 392.02M | 412.62M | 434.89M |
| Common Par | 1.30M | 1.06M | 1.05M | 1.04M |
| Additional Paid In Capital | 1.38B | 936.30M | 910.33M | 892.42M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -524.91M | -411.23M | -365.69M | -326.06M |
| Treasury Stock | -571.00K | -131.10M | -129.68M | -126.02M |
| Other Equity Adjustments | -2.71M | -3.01M | -3.39M | -6.48M |
| Total Capitalization | 1.30B | 392.02M | 412.62M | 485.11M |
| Total Equity | 853.85M | 392.02M | 412.62M | 434.89M |
| Total Liabilities & Stock Equity | 1.44B | 452.45M | 515.60M | 566.49M |
| Total Common Shares Outstanding | 130.18M | 96.08M | 95.25M | 94.91M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 35.08K | 10.07M | 9.95M | 9.51M |
| Basic Weighted Shares Outstanding | 114.70M | 95.61M | 94.84M | 95.16M |
| Diluted Weighted Shares Outstanding | 114.70M | 95.61M | 94.84M | 96.25M |
| Number of Employees | 1200 | 600 | 570 | 570 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with ALKS
- Portfolio NameUser Type
- ContributorEarnings Short Squeeze Play...
- ContributorStocks With Big Insider Buy...
- UserInvestments
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorBreakout Stocks Of The Week...
- Usergterryburns
- Usermitetwo Portfolio 1
- ContributorBreakout Stocks Of The Week...
- Contributor10 Biotech Stocks Facing FD...
Latest ALKS Headlines from TheStreet
- Cramer's 'Mad Money' Recap: Housing Comeback 05.10.12 | 08:05 pm
- 5 Stocks Insiders Love Right Now 05.02.12 | 11:05 am
- 8 Stocks Rising on Monster Volume 03.28.12 | 12:03 pm
- Insiders Trading TZYM, ALKS, CAKE 03.15.12 | 08:03 am
- The Curse of Amylin's Diabetes Drug Approval 02.06.12 | 08:02 am
- PharMerica, Amylin: After-Hours Trading 01.27.12 | 06:01 pm
- Third Time's The Charm for Approval of Amylin Diabetes Drug 01.27.12 | 03:01 pm
- 7 Stocks Rising on Huge Volume 01.25.12 | 02:01 pm
- UBS: 6 Specialty Pharma Picks to Watch 01.21.12 | 07:01 am
- Biotech Lessons Learned From JPM 2012 01.13.12 | 06:01 am
Press Releases for ALKS
- Alkermes’ Corporate Presentation To Be Webcast At Two Upcoming Conferences - Business Wire 05.31.12 | 07:05 am
- Alkermes Announces Results From Phase 2 Study Of ALKS 37 For Treatment Of Opioid-Induced Constipation - Business Wire 05.30.12 | 04:05 pm
- Alkermes Presents Positive Clinical Data Of ALKS 5461 At 52nd Annual New Clinical Drug Evaluation Unit Meeting - Business Wire 05.29.12 | 04:05 pm
- Alkermes Plc Completes Secondary Offering Of 24,150,000 Ordinary Shares Held By Elan - Business Wire 03.13.12 | 11:03 am
- Alkermes Plc Prices Secondary Offering Of 21,000,000 Ordinary Shares Held By Elan - Business Wire 03.08.12 | 09:03 am
- Alkermes Plc Announces A Secondary Offering Of 13,900,000 Ordinary Shares Held By Elan - Business Wire 03.07.12 | 04:03 pm
- Alkermes Appoints Mark Stejbach As Chief Commercial Officer - Business Wire 03.05.12 | 07:03 am
- Alkermes’ Corporate Presentation To Be Webcast At The Cowen & Company 32nd Annual Health Care Conference - Business Wire 02.27.12 | 04:02 pm
- Alkermes Files Resale Shelf Registration In Connection With Elan Shareholder Agreement - Business Wire 02.16.12 | 04:02 pm
- BYDUREONâ¢, First And Only Once-Weekly Type 2 Diabetes Treatment, Now Available In U.S. Pharmacies - PR Newswire 02.13.12 | 08:02 am
Partner Headlines for ALKS
- Healthcare Biz Recap: Teva's Counterfeit Problem, Hopes for Bristol-Myers - Wall St. Cheat Sheet 05.30.12 | 07:05 am
- Alkermes Earnings Call Insights: Adjusted EBITDA, VIVITROL - Wall St. Cheat Sheet 05.29.12 | 01:05 pm
- 9 High-Liquidity Mid Caps Poised For Growth - Seeking Alpha 05.28.12 | 08:05 am
- Long Undervalued, Is Alkermes Still A Bargain? - Seeking Alpha 03.30.12 | 09:03 am
- Kinetics Hedge Fund's Top Undervalued Picks - Seeking Alpha 03.23.12 | 05:03 pm
- Elan Sells 76% Stake in Alkermes - Analyst Blog - Zacks 03.16.12 | 05:03 pm
- Alkermes Announces a Secondary Offering of 13,900,000 Ordinary Shares Held by Elan - Benzinga 03.07.12 | 04:03 pm
- Bydureon Physician Survey: Results Yield Insight Into Launch Trajectory - Seeking Alpha 02.22.12 | 08:02 am
- The Zacks Analyst Blog Highlights: Charles Schwab, E*TRADE Financial, TD Ameritrade Holding, Amylin Pharmaceuticals and Alkermes plc - Press Releases - Zacks 02.16.12 | 09:02 am
- Analyzing Friday's Noteworthy Insider Buys And Sells - Seeking Alpha 02.12.12 | 07:02 am
